Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Rossi

Showing results (331-340 of 504) with videos related to

Pageof 51
Sort By:
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 11, 2023
Prevalence of amyloid in ligamentum flavum of patients with lumbar spinal stenosisFrancesco Marchi, Chiara Kessler, Daniela Distefano, et al.
Cancer Research|April 23, 2009
CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survivalAntonella Zucchetto, Dania Benedetti, Claudio Tripodo, et al.
Diagnostics (Basel, Switzerland)|March 29, 2023
Non-Functional Jaw Muscular Activity in Patients with Disorders of Consciousness Revealed by A Long-Lasting PolygraphyMartina Cacciatore, Francesca Giulia Magnani, Camilla Ippoliti, et al.
Haematologica|November 14, 2015
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemiaMaria Ilaria Del Principe, Michele Dal Bo, Tamara Bittolo, et al.
Blood|February 20, 2014
Genetic lesions associated with chronic lymphocytic leukemia chemo-refractorinessMonica Messina, Ilaria Del Giudice, Hossein Khiabanian, et al.
Haematologica|February 9, 2019
The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia modelsStuart W Hicks, Chiara Tarantelli, Alan Wilhem, et al.
Blood|August 20, 2013
Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label studyAlessandra Larocca, Vittorio Montefusco, Sara Bringhen, et al.
Hematological Oncology|June 3, 2022
Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinibAdalgisa Condoluci, Lisa Milan, Gabriela Forestieri, et al.
British Journal of Haematology|May 22, 2008
Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndromeDavide Rossi, Michaela Cerri, Daniela Capello, et al.
American Journal of Hematology|September 29, 2011
The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experienceLuca Laurenti, Michela Tarnani, Ilaria Nichele, et al.
Pageof 51

Showing results (331-340 of 504) with videos related to

Sort By:
Pageof 51
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 11, 2023
Prevalence of amyloid in ligamentum flavum of patients with lumbar spinal stenosisFrancesco Marchi, Chiara Kessler, Daniela Distefano, et al.
Cancer Research|April 23, 2009
CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survivalAntonella Zucchetto, Dania Benedetti, Claudio Tripodo, et al.
Diagnostics (Basel, Switzerland)|March 29, 2023
Non-Functional Jaw Muscular Activity in Patients with Disorders of Consciousness Revealed by A Long-Lasting PolygraphyMartina Cacciatore, Francesca Giulia Magnani, Camilla Ippoliti, et al.
Haematologica|November 14, 2015
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemiaMaria Ilaria Del Principe, Michele Dal Bo, Tamara Bittolo, et al.
Blood|February 20, 2014
Genetic lesions associated with chronic lymphocytic leukemia chemo-refractorinessMonica Messina, Ilaria Del Giudice, Hossein Khiabanian, et al.
Haematologica|February 9, 2019
The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia modelsStuart W Hicks, Chiara Tarantelli, Alan Wilhem, et al.
Blood|August 20, 2013
Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label studyAlessandra Larocca, Vittorio Montefusco, Sara Bringhen, et al.
Hematological Oncology|June 3, 2022
Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinibAdalgisa Condoluci, Lisa Milan, Gabriela Forestieri, et al.
British Journal of Haematology|May 22, 2008
Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndromeDavide Rossi, Michaela Cerri, Daniela Capello, et al.
American Journal of Hematology|September 29, 2011
The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experienceLuca Laurenti, Michela Tarnani, Ilaria Nichele, et al.
Pageof 51